메뉴 건너뛰기




Volumn 11, Issue 3, 2006, Pages 335-341

Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

EID: 33744726526     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (25)
  • 1
    • 0442268112 scopus 로고    scopus 로고
    • A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team
    • Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997; 337:725-733.
    • (1997) N Engl J Med , vol.337 , pp. 725-733
    • Hammer, S.M.1    Squires, K.E.2    Hughes, M.D.3
  • 2
    • 6844240219 scopus 로고    scopus 로고
    • Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
    • The Advanced HIV Disease Ritonavir Study Group
    • Cameron DW, Heath-Chiozzi M, Danner S, et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group. Lancet 1998; 351:543-549.
    • (1998) Lancet , vol.351 , pp. 543-549
    • Cameron, D.W.1    Heath-Chiozzi, M.2    Danner, S.3
  • 3
    • 0035965633 scopus 로고    scopus 로고
    • Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
    • Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. J Am Med Assoc 2001; 286:2568-2577.
    • (2001) J Am Med Assoc , vol.286 , pp. 2568-2577
    • Hogg, R.S.1    Yip, B.2    Chan, K.J.3
  • 4
    • 0037072066 scopus 로고    scopus 로고
    • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies
    • Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-129.
    • (2002) Lancet , vol.360 , pp. 119-129
    • Egger, M.1    May, M.2    Chêne, G.3
  • 6
    • 4444227111 scopus 로고    scopus 로고
    • Mortality in HIV-seropositive- Verus seronegative persons in the era of highly active antiretroviral therapy: Implications for when to initiate therapy
    • Wang C, Vlahov D, Galai N, et al. Mortality in HIV-seropositive- verus seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis 2004; 190:1046-1054.
    • (2004) J Infect Dis , vol.190 , pp. 1046-1054
    • Wang, C.1    Vlahov, D.2    Galai, N.3
  • 8
    • 2542452668 scopus 로고    scopus 로고
    • Rockville: A Service of the U.S Department of Health and Human Services; October 6
    • AIDSinfo [homepage on the Internet]. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Rockville: A Service of the U.S Department of Health and Human Services; 2005 October 6. Available from: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
    • (2005) Guidelines for the Use of Antiretroviral Agents in HIV-infected Adults and Adolescents
  • 10
    • 3042726798 scopus 로고    scopus 로고
    • Treatment for adult HIV infection. 2004 recommendations of the international AIDS society-USA panel
    • Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection. 2004 recommendations of the international AIDS society-USA panel. J Am Med Assoc 2004; 292:251-265.
    • (2004) J Am Med Assoc , vol.292 , pp. 251-265
    • Yeni, P.G.1    Hammer, S.M.2    Hirsch, M.S.3
  • 11
    • 0035944786 scopus 로고    scopus 로고
    • Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study
    • Devereaux PJ, Anderson DR, Gardner MJ, et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Br Med J 2001; 323:1-7.
    • (2001) Br Med J , vol.323 , pp. 1-7
    • Devereaux, P.J.1    Anderson, D.R.2    Gardner, M.J.3
  • 12
    • 0034843354 scopus 로고    scopus 로고
    • How do patients' treatment preferences compare with those of clinicians?
    • Montgomery AA, Fahey T. How do patients' treatment preferences compare with those of clinicians? Qual Health Care 2001; 10:39-43.
    • (2001) Qual Health Care , vol.10 , pp. 39-43
    • Montgomery, A.A.1    Fahey, T.2
  • 13
    • 0031717679 scopus 로고    scopus 로고
    • Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate
    • Nieuwkerk PT, Hajenius PJ, Van der Veen F, Ankum WM, Wijker W, Bossuyt PM. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertil Steril 1998; 70:518-522.
    • (1998) Fertil Steril , vol.70 , pp. 518-522
    • Nieuwkerk, P.T.1    Hajenius, P.J.2    Van Der Veen, F.3    Ankum, W.M.4    Wijker, W.5    Bossuyt, P.M.6
  • 14
    • 0031015328 scopus 로고    scopus 로고
    • Trading treatment toxicity for survival in locally advanced non-small cell lung cancer
    • Brundage MD, Davidson JR, Mackillop WJ. Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 1997; 15:330-340.
    • (1997) J Clin Oncol , vol.15 , pp. 330-340
    • Brundage, M.D.1    Davidson, J.R.2    Mackillop, W.J.3
  • 15
    • 0029813715 scopus 로고    scopus 로고
    • Warfarin for atrial fibrillation. The patient's perspective
    • Man-Son-Hing M, Laupacis A, O Connor A, et al. Warfarin for atrial fibrillation. The patient's perspective. Arch Intern Med 1996; 156:1841-1848.
    • (1996) Arch Intern Med , vol.156 , pp. 1841-1848
    • Man-Son-Hing, M.1    Laupacis, A.2    O Connor, A.3
  • 16
    • 33744759053 scopus 로고    scopus 로고
    • ART cohort collaboration [homepage on the internet]. ART cohort collaboration [updated 13 June; cited 28 November 2004]
    • ART cohort collaboration [homepage on the internet]. ART cohort collaboration [updated 13 June 2005; cited 28 November 2004] Available from: http://www.art-cohort-collaboration.org.
    • (2005)
  • 18
    • 0030666187 scopus 로고    scopus 로고
    • The role of numeracy in understanding the benfit of screening mammography
    • Schwartz LM, Woloshin S, Black WC, Welch HG. The role of numeracy in understanding the benfit of screening mammography. Ann Intern Med 1997; 127:966-972.
    • (1997) Ann Intern Med , vol.127 , pp. 966-972
    • Schwartz, L.M.1    Woloshin, S.2    Black, W.C.3    Welch, H.G.4
  • 19
    • 0035659080 scopus 로고    scopus 로고
    • 'I will start treatment when I think the time is right': HIV-positive gay men talk about their decision not to access antiretroviral therapy
    • Gold RS, Ridge DT. 'I will start treatment when I think the time is right': HIV-positive gay men talk about their decision not to access antiretroviral therapy. AIDS Care 2001; 13:693-708.
    • (2001) AIDS Care , vol.13 , pp. 693-708
    • Gold, R.S.1    Ridge, D.T.2
  • 20
    • 0036273470 scopus 로고    scopus 로고
    • Perceptions of HAART among gay men who declined a treatment offer: Preliminary results from an interview-based study
    • Cooper V, Buick D, Horne R, et al. Perceptions of HAART among gay men who declined a treatment offer: preliminary results from an interview-based study. AIDS Care 2002; 14:319-328.
    • (2002) AIDS Care , vol.14 , pp. 319-328
    • Cooper, V.1    Buick, D.2    Horne, R.3
  • 21
    • 4143110373 scopus 로고    scopus 로고
    • Review of determinants of patients' preferences for adjuvant therapy in cancer
    • Jansen SJT, Otten W, Stiggelbout AM. Review of determinants of patients' preferences for adjuvant therapy in cancer. J Clin Oncol 2004; 22:3181-3190.
    • (2004) J Clin Oncol , vol.22 , pp. 3181-3190
    • Jansen, S.J.T.1    Otten, W.2    Stiggelbout, A.M.3
  • 22
    • 0028307292 scopus 로고
    • Incorporating patients' preferences into medical decisions
    • Kassirer JP. Incorporating patients' preferences into medical decisions. N Engl J Med 1994; 330:1895-1896.
    • (1994) N Engl J Med , vol.330 , pp. 1895-1896
    • Kassirer, J.P.1
  • 23
    • 0031708733 scopus 로고    scopus 로고
    • Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology
    • Draycott S, Dabbs A. Cognitive dissonance. 1: An overview of the literature and its integration into theory and practice in clinical psychology. Br J Clin Psychol 1998; 37:341-353.
    • (1998) Br J Clin Psychol , vol.37 , pp. 341-353
    • Draycott, S.1    Dabbs, A.2
  • 24
    • 0035894169 scopus 로고    scopus 로고
    • Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
    • Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001; 28:445-449.
    • (2001) J Acquir Immune Defic Syndr , vol.28 , pp. 445-449
    • Ammassari, A.1    Murri, R.2    Pezzotti, P.3
  • 25
    • 0037192573 scopus 로고    scopus 로고
    • Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy
    • Dieleman JP, Jambroes M, Gyssens IC, et al. Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. AIDS 2002; 16:737-745.
    • (2002) AIDS , vol.16 , pp. 737-745
    • Dieleman, J.P.1    Jambroes, M.2    Gyssens, I.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.